Silibinin and Paclitaxel Cotreatment Significantly Suppress the Activity and Lung Metastasis of Triple Negative 4T1 Mammary Tumor Cell in Mice

The in vitro and in vivo bioactivities of silibinin (SB), paclitaxel (PTX) and SB and PTX in combination (SB+PTX) against murine metastatic mammary 4T1 cancer cell line were investigated. Isobologram and combination index (CI) analyses showed that SB and PTX can function synergistically in the inhib...

Full description

Bibliographic Details
Main Authors: Bing-Ying Ho, Chun-Hung Lin, Maria Karmella Apaya, Wen-Wan Chao, Lie-Fen Shyur
Format: Article
Language:English
Published: Elsevier 2012-10-01
Series:Journal of Traditional and Complementary Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S222541101630116X
_version_ 1811216665082331136
author Bing-Ying Ho
Chun-Hung Lin
Maria Karmella Apaya
Wen-Wan Chao
Lie-Fen Shyur
author_facet Bing-Ying Ho
Chun-Hung Lin
Maria Karmella Apaya
Wen-Wan Chao
Lie-Fen Shyur
author_sort Bing-Ying Ho
collection DOAJ
description The in vitro and in vivo bioactivities of silibinin (SB), paclitaxel (PTX) and SB and PTX in combination (SB+PTX) against murine metastatic mammary 4T1 cancer cell line were investigated. Isobologram and combination index (CI) analyses showed that SB and PTX can function synergistically in the inhibition of 4T1 cell proliferation with a CI value<1. Both SB and PTX alone or SB+PTX treatment inhibited 4T1 cell migration and motility possibly through downregulation of the serpin protease nexin-1 (PN-1) and N-cadherin expression, inhibition of matrix metalloprotease (MMP)-9 activity, and upregulation of E-cadherin. Flow cytometry and Western blot analyses demonstrated that both drugs deregulated cell-cycle mediators and induced apoptosis in 4T1 cells. A real-time in vivo bioluminescence imaging system to monitor the breast cancer cell metastasis in syngeneic BALB/c mice was established using a stable 4T1pGL−COX−2/Luc cell clone carrying a COX-2 promoter driven-luciferase reporter gene. In vivo study using the allograft 4T1pGL−COX−2/Luc metastatic mouse model indicated that SB co-treated with PTX can significantly suppress lung metastasis of 4T1 cells likely through inhibiting cell proliferation and angiogenesis. Together, this study demonstrates that SB could act synergistically with PTX in 4T1 cells, providing a therapeutic option for highly metastatic triple negative breast cancer.
first_indexed 2024-04-12T06:42:05Z
format Article
id doaj.art-028d5c0330b14e47a7c74e92cce3bf5e
institution Directory Open Access Journal
issn 2225-4110
language English
last_indexed 2024-04-12T06:42:05Z
publishDate 2012-10-01
publisher Elsevier
record_format Article
series Journal of Traditional and Complementary Medicine
spelling doaj.art-028d5c0330b14e47a7c74e92cce3bf5e2022-12-22T03:43:40ZengElsevierJournal of Traditional and Complementary Medicine2225-41102012-10-012430131110.1016/S2225-4110(16)30116-XSilibinin and Paclitaxel Cotreatment Significantly Suppress the Activity and Lung Metastasis of Triple Negative 4T1 Mammary Tumor Cell in MiceBing-Ying Ho0Chun-Hung Lin1Maria Karmella Apaya2Wen-Wan Chao3Lie-Fen Shyur4Agricultural Biotechnology Research Center, Academia Sinica, Taipei 115, TaiwanAgricultural Biotechnology Research Center, Academia Sinica, Taipei 115, TaiwanAgricultural Biotechnology Research Center, Academia Sinica, Taipei 115, TaiwanAgricultural Biotechnology Research Center, Academia Sinica, Taipei 115, TaiwanAgricultural Biotechnology Research Center, Academia Sinica, Taipei 115, TaiwanThe in vitro and in vivo bioactivities of silibinin (SB), paclitaxel (PTX) and SB and PTX in combination (SB+PTX) against murine metastatic mammary 4T1 cancer cell line were investigated. Isobologram and combination index (CI) analyses showed that SB and PTX can function synergistically in the inhibition of 4T1 cell proliferation with a CI value<1. Both SB and PTX alone or SB+PTX treatment inhibited 4T1 cell migration and motility possibly through downregulation of the serpin protease nexin-1 (PN-1) and N-cadherin expression, inhibition of matrix metalloprotease (MMP)-9 activity, and upregulation of E-cadherin. Flow cytometry and Western blot analyses demonstrated that both drugs deregulated cell-cycle mediators and induced apoptosis in 4T1 cells. A real-time in vivo bioluminescence imaging system to monitor the breast cancer cell metastasis in syngeneic BALB/c mice was established using a stable 4T1pGL−COX−2/Luc cell clone carrying a COX-2 promoter driven-luciferase reporter gene. In vivo study using the allograft 4T1pGL−COX−2/Luc metastatic mouse model indicated that SB co-treated with PTX can significantly suppress lung metastasis of 4T1 cells likely through inhibiting cell proliferation and angiogenesis. Together, this study demonstrates that SB could act synergistically with PTX in 4T1 cells, providing a therapeutic option for highly metastatic triple negative breast cancer.http://www.sciencedirect.com/science/article/pii/S222541101630116XSilibininPaclitaxelTriple negative breast cancerLung metastasisSynergistic effect
spellingShingle Bing-Ying Ho
Chun-Hung Lin
Maria Karmella Apaya
Wen-Wan Chao
Lie-Fen Shyur
Silibinin and Paclitaxel Cotreatment Significantly Suppress the Activity and Lung Metastasis of Triple Negative 4T1 Mammary Tumor Cell in Mice
Journal of Traditional and Complementary Medicine
Silibinin
Paclitaxel
Triple negative breast cancer
Lung metastasis
Synergistic effect
title Silibinin and Paclitaxel Cotreatment Significantly Suppress the Activity and Lung Metastasis of Triple Negative 4T1 Mammary Tumor Cell in Mice
title_full Silibinin and Paclitaxel Cotreatment Significantly Suppress the Activity and Lung Metastasis of Triple Negative 4T1 Mammary Tumor Cell in Mice
title_fullStr Silibinin and Paclitaxel Cotreatment Significantly Suppress the Activity and Lung Metastasis of Triple Negative 4T1 Mammary Tumor Cell in Mice
title_full_unstemmed Silibinin and Paclitaxel Cotreatment Significantly Suppress the Activity and Lung Metastasis of Triple Negative 4T1 Mammary Tumor Cell in Mice
title_short Silibinin and Paclitaxel Cotreatment Significantly Suppress the Activity and Lung Metastasis of Triple Negative 4T1 Mammary Tumor Cell in Mice
title_sort silibinin and paclitaxel cotreatment significantly suppress the activity and lung metastasis of triple negative 4t1 mammary tumor cell in mice
topic Silibinin
Paclitaxel
Triple negative breast cancer
Lung metastasis
Synergistic effect
url http://www.sciencedirect.com/science/article/pii/S222541101630116X
work_keys_str_mv AT bingyingho silibininandpaclitaxelcotreatmentsignificantlysuppresstheactivityandlungmetastasisoftriplenegative4t1mammarytumorcellinmice
AT chunhunglin silibininandpaclitaxelcotreatmentsignificantlysuppresstheactivityandlungmetastasisoftriplenegative4t1mammarytumorcellinmice
AT mariakarmellaapaya silibininandpaclitaxelcotreatmentsignificantlysuppresstheactivityandlungmetastasisoftriplenegative4t1mammarytumorcellinmice
AT wenwanchao silibininandpaclitaxelcotreatmentsignificantlysuppresstheactivityandlungmetastasisoftriplenegative4t1mammarytumorcellinmice
AT liefenshyur silibininandpaclitaxelcotreatmentsignificantlysuppresstheactivityandlungmetastasisoftriplenegative4t1mammarytumorcellinmice